Abstract

Stable encapsulation of medically active compounds can lead to longer storage life and facilitate the slow-release mechanism. In this work, the dynamic and molecular interactions between plumbagin molecule with β-cyclodextrin (BCD) and its two derivatives, which are dimethyl-β-cyclodextrin (MBCD), and 2-O-monohydroxypropyl-β-cyclodextrin (HPBCD) were investigated. Molecular dynamics simulations (MD) with GLYCAM-06 and AMBER force fields were used to simulate the inclusion complex systems under storage temperature (4 °C) in an aqueous solution. The simulation results suggested that HPBCD is the best encapsulation agent to produce stable host–guest binding with plumbagin. Moreover, the observation of the plumbagin dynamic inside the binding cavity revealed that it tends to orient the methyl group toward the wider rim of HPBCD. Therefore, HPBCD is a decent candidate for the preservation of plumbagin with a promising longer storage life and presents the opportunity to facilitate the slow-release mechanism.

Highlights

  • Plumbagin, or 2-methyljuglone, is an essential plant-based naphthoquinone that has been extensively used as a medicinal compound in Asian countries [1]

  • For plumbagin–MBCD inclusion complexes, in both conformations (MBCD-I and MBCD-II), the energies were steady at −9000 kcal/mol

  • between plumbagin molecule with β-cyclodextrin (BCD) can encapsulate plumbagin inside its inner cavity for some period of time, but its structural distortion triggers the release of plumbagin similar to MBCD

Read more

Summary

Introduction

2-methyljuglone, is an essential plant-based naphthoquinone that has been extensively used as a medicinal compound in Asian countries [1]. It exhibits several influential biological effects such as antioxidant, anti-inflammatory, anticancer, antibacterial, and antifungal activities [2]. Cytotoxic activity against lung and breast carcinoma has been reported in several studies [3,4,5]. Researchers have reported that nano-encapsulation of plumbagin with β-cyclodextrin (BCD) can reduce toxicity and enhance pharmaceutical efficacy [9,10]. Our works have reported the use of BCD and its derivatives to enhance the stability and aqueous solubility of plumbagin [11,12]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call